House Bill 1185
117th Congress(2021-2022)
Opioid Patients’ Right to Know Act of 2021
Introduced
Introduced in House on Feb 18, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1185
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
David Trone
grade
Maryland
Arizona
California
California
Connecticut
Delaware
Kentucky
Nebraska
New Hampshire
New Mexico
Pennsylvania
Pennsylvania
Rhode Island
Rhode Island
Washington
West Virginia
No House votes have been held for this bill.
Summary
Opioid Patients' Right to Know Act of 2021
This bill requires the Centers for Disease Control and Prevention to award grants to states to educate health care providers about opioid prescribing practices.
To receive a grant, a state must have a law or regulation that requires providers to, before issuing an initial opioid prescription to treat acute pain, inform patients about the risks of opioids and the availability of non-opioid treatment alternatives.
States must use the grants to educate providers about relevant laws or regulations and safe opioid prescribing recommendations.
February 18, 2021
02/19/2021
Referred to the Subcommittee on Health.
02/18/2021
Referred to the House Committee on Energy and Commerce.
02/18/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:47:19 PM